Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial. Adrienne E Shapiro , Elias Sarkis , Jude Acloque , Almena Free , Yaneicy Gonzalez-Rojas , Rubaba Hussain , Erick Juarez , Jaynier Moya , Naval Parikh , David Inman , Deborah Cebrik , Ahmed Nader , Nadia Noormohamed , Qianwen Wang , Andrew Skingsley , Daren Austin , Amanda Peppercorn , Maria L Agostini , Sergio Parra , Sophia Chow , Erik Mogalian , Phillip S Pang , David K Hong , Jennifer E Sager , Wendy W Yeh , Elizabeth L Alexander , Leah A Gaffney , Anita Kohli Open forum infectious diseases（2023）
摘要
ClinicalTrials.gov: NCT04913675.
更多 查看译文
关键词
clinical trial, sars-cov, comet-tail
AI 理解论文
溯源树
样例
